|
Phase I–II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints |
|
|
|
Titel: |
Phase I–II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints |
Auteur: |
Winqvist, Maria Mozaffari, Fariba Palma, Marzia Eketorp Sylvan, Sandra Hansson, Lotta Mellstedt, Håkan Österborg, Anders Lundin, Jeanette |
Verschenen in: |
Cancer, immunology, immunotherapy |
Paginering: |
Jaargang 66 (2016) nr. 1 pagina's 91-102 |
Jaar: |
2016 |
Inhoud: |
|
Uitgever: |
Springer Berlin Heidelberg, Berlin/Heidelberg |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|